» Articles » PMID: 32003480

Expanded Carrier Screening for Preconception Reproductive Risk Assessment: Prevalence of Carrier Status in a Mexican Population

Overview
Journal Prenat Diagn
Publisher Wiley
Date 2020 Feb 1
PMID 32003480
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Genetic carrier screening has the potential to identify couples at risk of having a child affected with an autosomal recessive or X-linked disorder. However, the current prevalence of carrier status for these conditions in developing countries is not well defined. This study assesses the prevalence of carrier status of selected genetic conditions utilizing an expanded, pan-ethnic genetic carrier screening panel (ECS) in a large population of Mexican patients.

Methods: Retrospective chart review of all patients tested with a single ECS panel at an international infertility center from 2012 to 2018 were included, and the prevalence of positive carrier status in a Mexican population was evaluated.

Results: Eight hundred five individuals were analyzed with ECS testing for 283 genetic conditions. Three hundred fifty-two carriers (43.7%) were identified with 503 pathogenic variants in 145 different genes. Seventeen of the 391 participating couples (4.34%) were identified as being at-risk couples. The most prevalent alleles found were associated with alpha thalassemia, cystic fibrosis, GJB2 nonsyndromic hearing loss, biotinidase deficiency, and familial Mediterranean fever.

Conclusion: Based on the prevalence and severity of Mendelian disorders, we recommend that couples who wish to conceive regardless of their ethnicity background explore carrier screening and genetic counseling prior to reproductive medical treatment.

Citing Articles

Carrier frequency estimation of pathogenic variants of autosomal recessive and X-linked recessive mendelian disorders using exome sequencing data in 1,642 Thais.

Chetruengchai W, Phowthongkum P, Shotelersuk V BMC Med Genomics. 2024; 17(1):9.

PMID: 38167091 PMC: 10762924. DOI: 10.1186/s12920-023-01771-w.


Determination of Carrier Frequency of Actionable Pathogenic Variants in Autosomal Recessive Genetic Diseases in the Turkish Cypriot Population.

Gunsel A, Ergoren M, Kemal H, Kafshboran H, Cerit L, Turgay A Genes (Basel). 2023; 14(10).

PMID: 37895316 PMC: 10606490. DOI: 10.3390/genes14101967.


Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.

Ont Health Technol Assess Ser. 2023; 23(4):1-398.

PMID: 37637488 PMC: 10453298.


Genetic Counselling Needs for Reproductive Genetic Carrier Screening: A Scoping Review.

Edwards S, Laing N J Pers Med. 2022; 12(10).

PMID: 36294838 PMC: 9605645. DOI: 10.3390/jpm12101699.


Clinical Utility of Medical Exome Sequencing: Expanded Carrier Screening for Patients Seeking Assisted Reproductive Technology in China.

Tong K, He W, He Y, Li X, Hu L, Hu H Front Genet. 2022; 13:943058.

PMID: 36072675 PMC: 9441495. DOI: 10.3389/fgene.2022.943058.